DC-Y13-27
Product Specifications
SKU
C15116-5mg
Additionnal Information
DC-Y13-27, a derivative of DC-Y13, is an inhibitor of YTHDF2 with a KD of 37.9 μM. It also upregulates FOXO3 and TIMP1 while downregulating MMP1, MMP3, MMP7, and MMP9. Additionally, it enhances the antitumor effects of radiotherapy and radio-immunotherapy and is implicated in intervertebral disc degeneration pathogenesis research.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6218032-01 0.1 mL
MEF2A (Myocyte Enhancer Factor 2A, ADCAD1, RSRFC4, RSRFC9) (MaxLight 550)
Sign In for Pricing
View Details MBS6218032-02 5x 0.1 mL
MEF2A (Myocyte Enhancer Factor 2A, ADCAD1, RSRFC4, RSRFC9) (MaxLight 550)
Sign In for Pricing
View Details GTR15378249 1 Vial
Lentiviral human SAV1 sgRNA gene knockout kit - Lentiviral human SAV1 sgRNA gene knockout kit (25)
Sign In for Pricing
View Details 
P9109-48C1 200 µL
PRL3 (PTP4A3, PRL-3, PRL-R, Protein Tyrosine Phosphatase Type IVA, Member 3, Protein-tyrosine Phosphatase 4a3, Protein-tyrosine Phosphatase Of Regenerating Liver 3) discontinued
Sign In for Pricing
View Details 
IRBAMLSESN1AP809120UL 1 Each
Rabbit Anti SESN1 Polyclonal Affinity Purified (PBS with 0.05% sodium azide and 50% glycerol, pH7.4) (Western Blot,ELISA)
Sign In for Pricing
View Details